- Home
- EBMT vs KROS Comparison
EBMT vs KROS Comparison
Compare EBMT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBMT | KROS |
|---|---|---|
| Founded | 1922 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.5M | 206.0M |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EBMT | KROS |
|---|---|---|
| Price | $22.23 | $11.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $24.00 | $21.86 |
| AVG Volume (30 Days) | 33.8K | ★ 159.2K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | 53.23 | ★ 146.00 |
| EPS | ★ 0.98 | N/A |
| Revenue | N/A | ★ $243,864,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.00 | $2,751.79 |
| P/E Ratio | $22.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.80 | $9.69 |
| 52 Week High | $24.66 | $22.55 |
Technical Indicators
Market Signals| Indicator | EBMT | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 39.53 | 54.30 |
| Support Level | $21.66 | $10.57 |
| Resistance Level | $22.87 | $11.56 |
| Average True Range (ATR) | 0.65 | 0.48 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 27.04 | 53.94 |
Price Performance
Historical ComparisonAbout EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.